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Abstract
The potential number of drug like small molecules is estimated to be between 1023 and 1060 while
current databases of known compounds are orders of magnitude smaller with approximately 108 com-
pounds. This discrepancy has led to an interest in generating virtual libraries by using hand crafted
chemical rules and fragment based methods to cover a larger area of chemical space and generate
chemical libraries for use in in silico drug discovery endeavors. Here it is explored to what extent
a recurrent neural network with long short term memory cells can figure out sensible chemical rules
and generate synthesizable molecules through training on existing compounds encoded as SMILES.
The networks can, to a large extent generate novel, but chemically sensible molecules. The properties
of the molecules are tuned by training on two different datasets consisting of fragment like molecules
and drug like molecules. The produced molecules and the training databases have very similar distri-
butions of molar weight, predicted logP, number of hydrogen bond acceptors and donors, number of
rotatable bonds and topological polar surface area when compared to their respective training sets.
The compounds are for the most cases synthesizable as assessed with synthetic accessibility (SA) score
and Wiley ChemPlanner.
Introduction
The number of potential drug like molecules
is huge due to the large flexibility and com-
binatorial potential of organic carbon, nitro-
gen and oxygen chemistry. The number has
been estimated to be between 1023 and 1060[1,
2, 3] and dwarfs the current largest databases
of chemical compounds, such as ChemBL[4]:
~2*106, PubChem[5] ~90*106and ChemSpider[6]
~60*106. It has therefore long been of interest
to generate virtual chemical libraries for in sil-
ico drug discovery purposes[7]. A strategy for
generation of a virtual library can be enumera-
tion of products from reaction of libraries of frag-
ments, which ensures the synthetic feasibility of
the product and the availability of the reaction
fragments can be taken into account[8]. Exam-
ples of software solutions to enumerate such col-
lections are eSynth[9] and iLibDiverse built upon
CombiGen[10], and there are also databases that
have already been developed, such as the GDB
sets[11, 12, 13]. Many pharmaceutical compa-
nies have also developed solutions to enumer-
ate compounds that are within their synthetic
reach and/or covered by their current patents,
thus defining a chemical space of compounds with
known synthetic routes and intellectual property
coverage[14, 15].
Deep neural networks have gained a lot of in-
terest for their ability to do feature extraction
and learn rules from presented training data. The
availability of graphics processing units (GPUs)
and CUDA enabled back-ends makes prolonged
training available at a modest cost. New regu-
larization schemes such as dropout[16] and noise
layers[17] has enabled larger and deeper net-
work architectures without extensive over fit-
ting. Task oriented architectures such as con-
volutional neural networks[18] (CNN) for spatial
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related data such as images, have led to improve-
ments in image analysis whereas recurrent neural
networks[19] (RNNs) have been successful for se-
quence based input. In RNNs, the state of the
network is propagated forward for each step of
the input sequence, enabling the network to al-
ter its internal state for each input step and thus
alter the output even though the weights are the
same in the network. The performance of RNNs
improved greatly with use of micro architectures
such as long short term memory (LSTM)[20] cells
and gated recurrent units (GRU)[19]. LSTM cells
are a pre configured micro architecture of a neu-
ral network, which has controlled gates for input,
forget and output. This enables the unit to keep
its internal state for longer stretches of sequential
input in the RNN, leading to an improvement of
the RNN performance. The cells can be com-
bined and stacked into architectures that have
interesting properties with regard to analysis of
textual or sequence-based inputs.
An interesting property of RNN’s is their
ability to be played forward and generate new
sequences[21]. This is done in an iterative man-
ner where the predicted character or next step
in the sequence is fed back into the RNN, al-
tering its state and leading to a new prediction
for the next step in the sequence. For molecules
it is possible to describe the full configuration
of atoms and connection using the condensed
SMILES notation[22]. Letters and special char-
acters are used to describe the topology of the
molecules. Here an RNN is applied to datasets
of SMILES strings, enabling the generation of vir-
tual compound libraries. The molecular proper-
ties of the novel virtual molecules are investigated
and compared with the training datasets and the
synthetic feasability evaluated by scoring and ret-
rosynthetic analysis through computer-aided syn-
thesis design (CASD).
Methods
Datasets
The clean drug like (p13) and the clean fragments
subset (p12) was downloaded in SMILES[22] for-
mat from the Zinc12[23, 24] website and un-
zipped. The order of the lines was shuffled with
the GNU core utilities[25] shuf command line
tool. A custom Python[26] script was used to
prefix the SMILES with a start character “!”
and padded with an end character “E” to a fi-
nal length two characters longer than the longest
SMILES string in the set. The SMILES sets
were subsequently vectorized by one hot encod-
ing into HDF5[27] data files. The character-to-
index translation information was saved for each
dataset.
Neural Network
A RNN was built by using Keras[28] with
Theano[29] as the computation back end. First
two layers were constructed consisting of 256
LSTM[20] units run in batch mode with an input
layer matching the number of vectorized charac-
ters and the length of the padded SMILES. This
was followed by a time distributed feed forward
network consisting of two hidden layers with 128
neurons with rectified linear activation. The final
output layer matched the number of characters
in the dataset index with a soft-max activation.
The LSTM units were regularized with an input
dropout[16] of 0.1 (dropout_W).
The neural network was trained by reading
chunks of 100.000 vectorized SMILES into mem-
ory which were used in mini-batches of 512 for
one epoch of training for each chunk. The first
chunk was reserved for use as a validation set dur-
ing training. The learning rate was initially set
to 0.007 but gradually lowered if the validation
loss did not improved within the last five chunks
of training.
Sampling
A sampling model was built with the exact same
architecture as the training model, except the
LSTM layers were run in stateful mode instead of
batch mode and the input dimension set to a vec-
tor size of the number of characters in the dataset
vectorization dictionary. The output probabili-
ties were adjusted with a sampling temperature,
that rescales the probabilities in the output vec-
tor with the following formula:
pnew = e
ln(
pori
temp
)
Final selection of the next character was then
done with NumPy’s multinomial sampler. The
networks state was reset before SMILES genera-
tion and the initial character fed to the network
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was the start character “!”. Sampling was termi-
nated when the end character “E” was predicted.
The start and end characters were stripped and
the SMILES molecular validity checked by con-
version to a sanitized molecule with RDKit[30].
Two datasets of 50.000 molecules were gener-
ated with both trained models at a sampling tem-
perature of 1.0. Using RDKit, they were con-
verted to canonical SMILES, as were the train-
ing sets. The number of similar molecules was
found by intersecting the generated set with the
corresponding full training set.
Calculation of Molecular Properties
The two generated datasets were compared with
random samples of 50.000 molecules of both
training sets. RDKit was used to calculate a
range of molecular properties: the number of
hydrogen bond acceptors, number of hydrogen
bond donors, total polar surface area, number
of rotatable bonds and the molecular weight
as well as the predicted LogP[31]. In addi-
tion, the SA-score[32] was calculated on com-
pounds with the sascorer module from the RD-
Kit SA_score contribution package. The com-
pounds were converted to neutral form with the
MolVS package[33] before the synthetic acces-
sibility (SA) score was computed. Comparison
plots were made with Matplotlib[34].
All computations and training were done on a
Linux workstation (Ubuntu Mate 16.04) with 4
GB of RAM, i5-2405S CPU @ 2.50GHz and an
Nvidia Geforce GTX1060 graphics card with 6
GB of RAM.
Retrosythetic analysis
Compounds were selected for retro-synthetic
analysis by sampling the 10 compounds near-
est the 5, 50 and 95%th percentile of the SA
score distribution as well as the compound with
the highest SA score. Compounds already found
in the training sets were discarded. Each com-
pound was subjected to retro-synthetic analy-
sis with the Wiley ChemPlanner software[35] on
the default settings. The longest linear route to
any intermediate in the synthesis tree was three
steps and common reaction rules were employed.
Reaction rules are defined as common if there
are 50 or more supporting similar examples in
Figure 1: Training history for the fragment-like
dataset (p12).
the ChemPlanner training database, uncommon
if there are between 25 and 49 supporting simi-
lar examples in the training database, and rare
if there are between 5 and 24 supporting similar
examples in the training database. Routes were
completed until commercially available starting
materials with a cost less than 1000$/mol were
found. If it was not possible to generate a route
to commercially available starting materials with
the default settings, the maximum number of lin-
ear steps was increased to four, then the sequence
three steps with uncommon rules, three steps
with rare rules, four steps with uncommon rules,
and four steps with rare rules was applied until
a solution was found. If no feasible routes were
generated, the starting materials generated in the
first round of retrosynthetic planning were sub-
mitted to up to two more retrosynthetic planning
queries using all possible combinations of number
of steps and rules.
Results
Training was done for 352 chunks for p12
(fragment-like) and 449 chunks for p13 (drug-
like). The training history for p12 is shown in
Figure 1. The training history for p13 looks es-
sentially similar (not shown), although a slightly
lower final validation loss of 0.167 was obtained.
As p12 contains 1.611.889 SMILES and p13 had
13.195.609, this corresponds to approximately 22
and 3.5 passes over the entire datasets, respec-
tively. The difference between the validation
loss and training loss were negligible for both
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Figure 2: Examples of generated molecules from the
model trained on drug like molecules (p13).
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Figure 3: Examples of molecules generated from
the model trained on the dataset with molecular frag-
ments (p12).
datasets.
Examples of the molecules generated with
the model trained on drug-like molecules are
shown in Figure 2 . At a glance there seem
to be correctly made six membered benzene
rings and some five membered heterocyclic rings
which makes electronic sense according to RD-
Kit. Fused ring systems are also present.
Nitrogens in amides and near aromatic rings
appear uncharged, whereas primary and sec-
ondary aliphatic amines are charged, reflecting
the charge normalization of the training set done
by the Zinc database. The molecules generated
from the model trained on fragments on average
appear to be smaller and simpler (Figure 3 ).
Some of the generated SMILES strings were
malformed during sampling and could not be
parsed with RDKit. The fraction of the molecules
that contains errors was dependent on the sam-
Figure 4: Molecular sampling error at different sam-
pling temperature. High sampling temperatures leads
to malformed SMILES strings.
pling temperature with approximately 2% being
malformed at a temperature of 1.0 (Figure 4 ). At
temperatures over 1.2 the error rate rises signif-
icantly. Typical errors preventing SMILES pars-
ing were missing closure of parentheses or un-
matched ring closures. Occasionally the valence
of atoms was wrong.
37% of the generated fragments were found in
the training set, whereas only 17% of the gener-
ated drug-like molecules were found in the train-
ing set.
Comparison of molecular features
The properties of the molecules generated match
the properties of the molecules used for training
of the neural networks. Figure 5 show the his-
tograms of the properties for both samples of the
training sets and generated sets. The distribution
of the properties of the generated molecules to a
large extent overlaps with the distribution found
in the two training sets. The differences between
the two training sets reflects the filtering done
by the Zinc database to define the dataset. The
fragments are defined as molecules with xlogp
<=3.5 and mwt <=250 and rotatable bonds <=
5, whereas the drug like molecules have a mo-
lar weight between 150 and 500, xlogp <= 5
and the number of rotatable bonds <=7. Ad-
ditionally the drug like molecules must have a
polar surface area below 150, number of hydro-
gen bond donors <= 5 and number of hydrogen
bond acceptors <= 10. The difference between
the two datasets are most pronounced for the
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Figure 5: Calculated property distributions of the generated molecules. The generated molecules distribution
of properties (dashed lines) matches the training sets (solid lines) used for all calculated properties: Molecular
weight (MW), calculated LogP (LogP), total polar surface area (TPSA), number of hydrogen bond acceptors
(HBA), number of hydrogen bond donors (HBD) and number of rotatable bonds. p12 and p13 are the Zinc sets
for clean fragments and clean drug like molecules, respectively.
Figure 6: SA score distribution for 50.000 compound
samples of generated molecules and training sets. The
SA scores fo the generated molecules closely follows
the SA score of their respective training sets. p12 and
p13 are clean fragments and clean drug-like molecules
respectively.
molecular weight histograms, where the filtering
of the training sets are evident as sharp cutoffs in
the histograms. The generated training sets fol-
low this sharp edge only partially, but they also
generate a few molecules with a larger molecular
weight than found in the training sets as evident
from the thin tails.
The synthetic feasibility of the generated
molecules seem to very closely follow the train-
ing sets as assessed by the SA score[32] (Fig-
ure 6) This score uses a combination of fragment
contributions and assessed topological complex-
ity of the molecule, such as presence of unusual
ring systems, stereo complexity and molecular
size[32]. The distributions of the generated and
training sets are essentially similar.
To further investigate the synthesizability
of the generated molecules, three groups of
compounds were selected from the drug-like
molecules based on their SA score. A summary
of the properties of the identified synthetic rules
for each group are shown in Table 1. ChemPlan-
ner generated retrosynthetic routes for all com-
pounds in the easy group with the default set-
tings. For the medium group, possible problems
were noted for two out of six selected compounds,
and the second highest ranked route was chosen
for one of them. A route to one of the compounds
in the hard group could not be established, even
though the number of steps was and more rare
reaction rules were applied. Moreover, for the
compound with the highest SA score, no route
was identified from commercially available start-
ing materials. The summary in Table 1 illustrates
the expected differences between the groups. The
highest proportion of possible selectivity issues
was found in the group with the highest SA score
and this group required the most steps, would be
expected to give the lowest overall yield and had
the highest average cost of the starting materials.
The number of synthetic routes was larger for the
hard group possibly reflecting the larger amount
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Table 1: Average properties of the retro-synthetic routes found by ChemPlanner for three groups sampled near
the 5, 50 and 95%th percentiles of the SA score distribution
Group Possible
Selectivity
Issues
SA Score No. of
synthesis
routes
Max steps Yield / % Cost of SMs
US$/100g
Easy 0/6 1.9 26.0 2.2 55.7 1043.8
Medium 1/6 2.7 40.0 3.7 35.2 1690.8
Hard 4/9 3.7 42.1 4.4 26.1 1717.3
of combinations for longer synthetic routes with
more intermediates. The full table with details
on each sampled compound can be found in the
Supplementary Information.
Discussion
The most obvious question to ask of the auto-
matically created novel molecules is regarding
their practical synthesizability. The created com-
pounds complexity, topology and created frag-
ments closely matches the ones found in the
training set, which are already synthesized com-
pounds. The calculated SA scores thus seem to
match very closely and is in the easy to medium
end of the range and matches the SA scores
observed for catalog compounds in the original
study[32]. Using Wiley ChemPlanner[35], three
groups of molecules were subjected to retrosyn-
thetic planning. For the majority of compound
retrosynthetic routes could be identified (c.f. Ta-
ble 1). There seemed to be a larger proportion
of possible problems with compounds from the
group with the highest SA scores, indicating that
the SA score could be used as a first screen of
the generated compound before further detailed
evaluation if synthesizability and cost is an issue.
The SA scores are however in the medium to low
range when compared to the scores reported[32],
illustrating that for all except the easiest cases,
the compounds should be more detailed evalu-
ated by retro-synthetic software[35] operated by
trained medicinal chemists.
The sampling provided novel molecules, 63%
and 83% which were not found in the training set,
for the fragment-like and drug-like sets, respec-
tively. The larger drug-like molecules were more
novel, even if the training set was almost an order
of magnitude larger and thus represents a larger
sampling set in which to re-find a given molecule.
This is possibly due to a larger possible combi-
natorial space for the atomic connections of the
molecules. Considering the large estimated num-
bers of drug like molecules (see above), it is sur-
prising that the recurrent network generates such
a large proportion of molecules already found in
the training sets. This indicates over fitting of the
networks, which is not apparent from the training
graphs, Figure 1, and the similarity of the final
loss function from the training and test set. This
could reflect that the training and test sets are
too similar in properties: The original database
could contain a high proportion of compound se-
ries that have been split into both the training
and test sets. This effect could possibly be mit-
igated by performing a clustering based on scaf-
folds as encoded by circular fingerprints followed
by a division into training and test set based on
clusters. This could ensure a setting of hyper-
parameters that makes the networks cover more
diverse areas of chemical space. As it is now, the
networks seem to only generates molecules in the
vicinity of the training molecules, leading only to
a small expansion of the chemical space covered.
On the other hand, this propensity to generate
molecules in the vicinity of the training sets could
be used to generate molecules similar to com-
pound with known biological activity. However,
the small size of the datasets with known actives
easily leads to extensive overfitting, although lim-
ited retraining of previously trained networks
seems promising[36]. Techniques such as data
augmentation with SMILES enumeration could
also be of potential use[37]. A recent publica-
tion used a similar approach with reinforcement
learning to tune a generative RNN for produc-
ing molecules and additionally demonstrated how
the network could be tuned towards generating
molecules that potentially have bioactivity[38].
The close link between the training set and
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the generated molecules could potentially lead
to interesting iterative approaches in in silico
drug discovery resembling genetic algorithms.
The network could be used to generate a set of
molecules which are subsequently evaluated with
QSAR models or molecular docking. The best
half is then used to retrain the network. After
a couple of cycles the produced molecules would
likely have better properties in the in silico mod-
els.
Conclusion
Recurrent neural networks with LSTM cells can
be trained to generate novel and chemically plau-
sible molecules as assessed by SA score and retro-
synthetic analysis with Wiley ChemPlanner. The
distribution of the molecular properties of the
generated molecules closely resembles the prop-
erty distributions in the used training sets, mak-
ing it possible to tune the networks by filtering
the datasets. This possibility leads to novel op-
portunities for expanding known compound se-
ries with similar compounds of matched proper-
ties for generation of larger in silico compound
libraries. There was a correlation between the
SA score and the properties of the retrosynthetic
routes, although no routes could be generated for
two of the compounds selected for detailed anal-
ysis.
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